Table 1. Survival analysis of JAK1 mRNA in breast cancer patients (the PrognoScan).
| Dataset | Endpoint | Number | ln(HR-high / HR-low) | COX P-value | ln(HR) | HR [95% CI-low CI-up] |
| GSE6532-GPL570 | Distant Metastasis Free Survival | 87 | -1.4754 | 0.00994975 | -1.12962 | 0.32 [0.14 - 0.76] |
| Relapse Free Survival | 87 | -1.4754 | 0.00994975 | -1.12962 | 0.32 [0.14 - 0.76] | |
| GSE9195 | Distant Metastasis Free Survival | 77 | -1.47946 | 0.0298085 | -1.45055 | 0.23 [0.06 - 0.87] |
| Relapse Free Survival | 77 | -1.9106 | 0.00153696 | -1.99732 | 0.14 [0.04 - 0.47] | |
| GSE12093 | Distant Metastasis Free Survival | 136 | -1.43922 | 0.00834641 | -1.32906 | 0.26 [0.10 - 0.71] |
| GSE11121 | Distant Metastasis Free Survival | 200 | -1.44394 | 7.21E-05 | -1.88215 | 0.15 [0.06 - 0.39] |
| GSE9893 | Overall Survival | 155 | -1.34982 | 2.38E-05 | -0.85606 | 0.42 [0.29 - 0.63] |
| GSE1456-GPL96 | Relapse Free Survival | 159 | -1.57388 | 0.000196418 | -1.8311 | 0.16 [0.06 - 0.42] |
| Disease Specific Survival | 159 | -1.71397 | 0.000386357 | -2.05196 | 0.13 [0.04 - 0.40] | |
| Overall Survival | 159 | -1.42147 | 0.00026008 | -1.8023 | 0.16 [0.06 - 0.43] | |
| GSE3494-GPL96 | Disease Specific Survival | 236 | -0.669629 | 0.0294883 | -0.992049 | 0.37 [0.15 - 0.91] |
| GSE7390 | Distant Metastasis Free Survival | 198 | -1.99773 | 0.0381827 | -0.565258 | 0.57 [0.33 - 0.97] |
| Relapse Free Survival | 198 | -0.994522 | 0.150523 | -0.335991 | 0.71 [0.45 - 1.13] | |
| Overall Survival | 198 | -2.58196 | 0.0381021 | -0.585365 | 0.56 [0.32 - 0.97] |